A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs

Journal of Physiology and Pharmacology

Volumn 63, Issue 1, 2012, Pages 41-52

  Takayama, S ^a   Izuhara, C ^a   Yamada, N ^a   Yamanaka, S ^a   Hashimoto, E ^a   Kaneko, S ^a   Takeuchi, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antiulcer drugs; Aspirin; Clopidogrel; Gastric acid secretion; Gastric bleeding; Hemoglobin; Histamine; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FAMOTIDINE; HEMOGLOBIN; HISTAMINE; IRSOGLADINE MALEATE; MYELOPEROXIDASE; OMEPRAZOLE; REBAMIPIDE; TEPRENONE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DUODENUM; ENZYME ACTIVITY; ESOPHAGUS; LOW DRUG DOSE; MALE; NONHUMAN; RAT; STOMACH; STOMACH ACID SECRETION; STOMACH HEMORRHAGE; STOMACH MUCOSA; STOMACH ULCER;

ANIMALS; ANTI-ULCER AGENTS; ASPIRIN; DRUG INTERACTIONS; FAMOTIDINE; GASTRIC ACID; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; MALE; OMEPRAZOLE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; TICLOPIDINE;

EID: 84859113574     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Br Med J 1994; 308: 81-106.
2. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-1899.
3. Ng FH, Wong SY, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003; 18: 443-449.
4. Ibanez L, Vidal X, Vendrell L, Moretti U, Laporte JR. Spanish-Italian collaborative group for the epidemiology of gastrointestinal bleeding: upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006; 23: 235-242.
5. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. Br Med J 2006; 333: 726.
6. Yasuda H, Yamada M, Sawada S, et al. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting. Intern Med 2009; 48: 1725-1730.
7. Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010; 363: 1909-1917.
8. Gill JM, Player MS, Metz DC. Balancing the risks and benefits of proton pump inhibitors. Ann Fam Med 2011; 9: 200-202.
9. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113: 340-345.
10. Yamasaki K, Izuhara C, Honda M, Nishio H, Takeuchi K. Aggravation by clopidogrel, an antiplatelet drug, of antral ulcers induced by NSAID in rats: a prophylactic effect of famotidine (abstract in English). Pharma Medica 2009; 27: 106-115.
11. Izuhara C, Yamasaki K, Honda M, Nishio H, Takeuchi K. Aggravation by clopidogrel, an anti-platelet drug, of HCl/aspirin-induced gastric bleeding and lesions in rats: prophylactic effect of rebamipide (abstract in English). Jap Pharmacol Ther 2010; 38: 333-345.
12. Izuhara C, Takayama S, Yamada N, Kimura M, Takeuchi K. Aggravation by clopidogrel, an antiplatelet drug, of HCl/aspirin-induced gastric hemorrhagic lesions in rats: prophylactic effect of irsogladine (abstract in English). Jpn Pharmacol Ther 2011; 39: 421-435.
13. Konturek SJ. Gastric secretion-from Pavlov's nervism to Popielski's histamine as direct secretagogue of oxyntic glands. J Physiol Pharmacol 2003; 54(Suppl 3): 43-68.
14. Holzer P, Pabst MA, Lippe I.Th. Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 1986; 96: 1425-1433.
15. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350.
16. Okabe S, Takeuchi K, Nakamura K, Takagi K. Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rats. Jpn J Pharmacol 1974; 24: 363-371.
17. Ghassemi KA, Kovacs TO, Jensen DM. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Curr Gastroenterol Rep 2009; 11: 462-469.
18. van Rensburg C, Barkun AN, Racz I, et al. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment Pharmacol Ther 2009; 229: 497-507.
19. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for he prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-2383.
20. Ritchie WP. Acute gastric mucosal damage induced by bile salts, acid, and ischemia. Gastroenterology 1975; 68: 699-707.
21. Davenport HW. Gastric mucosal hemorrhage in dogs. Effects of acid, aspirin, and alcohol. Gastroenterology 1969; 56: 439-449.
22. Takeuchi K, Ueki S, Tanaka H. Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage. Am J Physiol 1986; 250: G842-G849.
23. Mashita Y, Taniguchi M, Yokota A, Tanaka A, Takeuchi K. Oral but not parenteral aspirin up-regulates COX-2expression in rat stomachs: a relationship between COX-2 expression and PG deficiency. Digestion 2006; 73: 124-132.
24. Guth PH, Aures D, Paulsen G. Topical aspirin plus HCl gastric lesions in the rat: cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology 1979; 76: 88-93.
25. Lin KJ, Hernadez-Diaz S, Rodriguez LA. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology 2011; 141: 71-79.
26. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301: 937-944.
27. Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-995.
28. Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors: emphasis on rabeprazole. Aliment Pharmacol Ther 1999; 13(Suppl 3): 27-36.
29. Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J. Influence of omeprazole on the antiplatelet action of clopidogrel associated to aspirin J Thromb Haemost 2006; 4: 2508-2509.
30. Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009; 101: 714-719.
31. Sambol NC, Upton RA, Chremos AN, Lin ET, Williams RL. A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow. Br J Clin Pharmacol 1989; 27: 83-87.
32. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992; 212: 9-13.
33. Sakurai K, Osaka T, Yamasaki K. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Dig Dis Sci 2005; 50: S90-S96.
34. Ohashi Y, Aihara E, Takasuka H, Takahashi K, Takeuchi K. Antral ulcers induced by alendronate, a nitrogen-containing bisphosphonate, in rat stomachs; prophylactic effect of rebamipide. J Physiol Pharmacol 2009; 60: 85-93.
35. Ueda F, Ban K, Ishima T. Irsogladine activates gap junctional intercellular communication through M1 muscarinic acetylcholine receptor. J Pharmacol Exp Ther 1995; 274: 815-819.
36. Kyoi T, Noda K, Oka M, Ukai Y. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci 2004; 76: 71-83.
37. Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986; 33: 206-210.
38. Suemasu S, Tanaka K, Namba T, et al. A Role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem 2009; 284: 19705-19715.